Modalis Therapeutics

Modalis Therapeutics company information, Employees & Contact Information

Updated May 2026

Quick answer

Modalis Therapeutics is a Biotechnology Research company and founded in 2016. It has approximately 22 employees on record. Contact data was last refreshed in May 2026. Find Modalis Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Modalis Therapeutics email format Modalis Therapeutics management contacts

Related company profiles:

Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,

Company Details

Employees
22
Founded
-
Address
51 Moulton St, Cambridge,massachusetts 02138,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
http://www.modalistx.com
Keywords
jobs.
HQ
Cambridge, Massachusetts
Competitors
Atamyo Therapeutics, Vertex Pharmaceuticals, Nvelop Therapeutics, Voyager Therapeutics, Inc., ImmPACT Bio, Interius BioTherapeutics, JCR Pharmaceuticals, Alnylam Pharmaceuticals, Lyell Immunopharma, Sangamo Therapeutics, Inc..
Looking for a particular Modalis Therapeutics employee's phone or email?

Modalis Therapeutics Questions

News

Press Release Service: JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy - CRISPR Medicine News

Press Release Service: JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy CRISPR Medicine News

Modalis Announces Partnership with Ginkgo Bioworks - The AI Journal

Modalis Announces Partnership with Ginkgo Bioworks The AI Journal

Press Release Service: Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD). - CRISPR Medicine News

Press Release Service: Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD). CRISPR Medicine News

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Business Wire

SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy Business Wire

Press Release Service: Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD) - CRISPR Medicine News

Press Release Service: Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD) CRISPR Medicine News

Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD) - CRISPR Medicine News

Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD) CRISPR Medicine News

Companies like Modalis Therapeutics

Alnylam Pharmaceuticals logo - Similar company to Modalis Therapeutics

Alnylam Pharmaceuticals

2.58K
Sangamo Therapeutics, Inc. logo - Similar company to Modalis Therapeutics

Sangamo Therapeutics...

267
Lyell Immunopharma logo - Similar company to Modalis Therapeutics

Lyell Immunopharma

253
Interius BioTherapeutics logo - Similar company to Modalis Therapeutics

Interius Biotherapeu...

57
Nvelop Therapeutics logo - Similar company to Modalis Therapeutics

Nvelop Therapeutics

10
ImmPACT Bio logo - Similar company to Modalis Therapeutics

Immpact Bio

64
Atamyo Therapeutics logo - Similar company to Modalis Therapeutics

Atamyo Therapeutics

4
JCR Pharmaceuticals logo - Similar company to Modalis Therapeutics

Jcr Pharmaceuticals

124
Vertex Pharmaceuticals logo - Similar company to Modalis Therapeutics

Vertex Pharmaceuticals

6.09K
Voyager Therapeutics, Inc. logo - Similar company to Modalis Therapeutics

Voyager Therapeutics...

177

Top Modalis Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant